U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications

Label updates include simplified twice-yearly echo monitoring for eligible CAMZYOS patients in the maintenance phase and expanded patient eligibility with reduced contraindications Updated U.S. label is supported by data including long-term clinical and real-world evidence which reinforce the strong safety profile of CAMZYOS PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #CAMZYOS—Bristol Myers Squibb (NYSE: BMY) today announced that the … [Read more…]

Claritev Further Strengthens Leadership Team as Part of Business Transformation Strategy

Jigar S. Patel, MD, Named Chief Medical Officer Fernando Schwartz, Ph.D., Named Chief Artificial Intelligence Officer MCLEAN, Va.–(BUSINESS WIRE)–$CTEV #CTEV–Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the following newly created appointments to its senior leadership … [Read more…]

Amlodipine (CAS 88150-42-9) Industry Report 2025: Global and Regional Market Trends 2019-2024 and Forecasts 2025-2029 – Manufacturers, Market Prices, Patents, Down-stream Industries – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Amlodipine (CAS 88150-42-9) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. This report on Amlodipine provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves … [Read more…]

Strive Health Expands Executive Team

Paul Marchetti is named President and Jen Browne is promoted to Chief Operating Officer DENVER–(BUSINESS WIRE)–Strive Health, the national leader in value-based kidney care, announced today that it has expanded its executive team. Paul Marchetti has been named Strive’s new President, overseeing all operations, customer success and growth. Jen Browne has been promoted to Chief … [Read more…]

Artedrone Successfully Demonstrates the Ability to Autonomously Perform End to End Mechanical Thrombectomy in Various Preclinical Studies With the Revolutionary SASHA Autonomous Micro-Robotic Solution

Pre-Clinical Results Demonstrate the Potential of SASHA platform in democratizing mechanical thrombectomy procedures, marking a paradigm shift in stroke treatment New research findings build on Company momentum following recent appointment of Liane Teplitsky as CEO and addition of Nnamdi Njoku and Dan Raffi to Board of Directors PARIS–(BUSINESS WIRE)–Artedrone, Truffle Capital’s medtech portfolio company developing … [Read more…]

Galderma launches new ALASTIN Restorative Skin Complex with Next Generation TriHex Technology®

ALASTIN by Galderma, a leader in professional grade skincare, unveils its latest innovation clinically proven to help rejuvenate skin ZUG, Switzerland–(BUSINESS WIRE)–Galderma Group AG (SWX:GALD), the pure-play dermatology category leader, announced today that ALASTIN, a leader in medical-grade peptide-based regenerative skincare, has officially launched their latest skincare innovation with the introduction of Restorative Skin Complex … [Read more…]

Ivy Fertility Centers Named Among Top Fertility Clinics in America

SAN DIEGO–(BUSINESS WIRE)–Dallas IVF, Fertility Associates of Memphis, Nevada Center for Reproductive Medicine, Northern California Fertility Medical Center, Pacific Northwest Fertility, Reproductive Partners Medical Group, San Diego Fertility Center, Virginia Fertility & IVF were all included on the list of the 140 best clinics in the country. These fertility centers are all part of Ivy … [Read more…]

Veracyte to Release First Quarter 2025 Financial Results on May 7, 2025

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will release financial results for the first quarter of 2025 after the close of market on Wednesday, May 7, 2025. Company management will host a conference call and webcast to discuss financial results and provide a general business … [Read more…]

Bayer Unveils $44 Million Investment in Myerstown, PA Manufacturing Facility, Renewing Commitment to U.S. Innovation, Health and Community

The facility’s new space enhances the company’s Consumer Health production capabilities, embraces automation, and invests in workforce development and community engagement MYERSTOWN, Pa.–(BUSINESS WIRE)–Today, Bayer proudly celebrated the grand opening of its new 70,000 square foot expansion at its Myerstown facility, following a $44 million investment in 2022. This state-of-the-art facility is a testament to … [Read more…]